Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Treasury bond issuance volume halves? Just two weeks ago it was at a high, now 1.5 billion USD in new bonds is about to be issued

Treasury bond issuance volume halves? Just two weeks ago it was at a high, now 1.5 billion USD in new bonds is about to be issued

汇通财经汇通财经2026/06/04 12:51
Show original
  1. The US Treasury will auction $75 billion of 1-month Treasury bills (maturing July 7, 2026) and $75 billion of 2-month Treasury bills (maturing August 4, 2026) on Thursday. Based on settlement on June 9, this issuance will bring about $15 billion in cash inflow. The auction schedule is: non-competitive bids close at Wednesday 23:00 (UTC+8), competitive bids close at Wednesday 23:30 (UTC+8).
  2. In terms of issuance scale, the current auction volume has decreased significantly compared to two weeks ago. Due to the supply contraction, some demand is expected to emerge. However, institutions point out that some believe the reason to buy these securities is—if issuance reductions lead to lower overnight collateral rates, it will bring positive carry opportunities—but this view is not fully convincing. Regarding forward roll, the 1-month Treasury bill’s roll value is about 0.3 basis points, which has some appeal; the 2-month roll value is only 0.6 basis points, and compared to the weekly spread of about 2.7 basis points between the 2-month and 3-month bills, it has no practical value.
  3. Historical auction statistics (based on the average of the past six times): the 1-month bill’s bid-to-cover ratio is 2.80, with indirect bidders accounting for 58.94%, direct bidders 4.44%, and dealers 36.61%. The 2-month bill’s bid-to-cover ratio is 2.93, with indirect bidders accounting for 50.84%, direct bidders 3.48%, and dealers 27.53%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Henry Schein shares fall after appointing new Chief Financial Officer

October 8 - ** Shares of dental products distributor Henry Schein (HSIC.O) dropped 2% to $82 in pre-market trading. ** Ronald South, who has served as CFO for the past four years, will transition to Senior Advisor. ** Emmanuel Caprais will take over as CFO, officially assuming the role on November 4. ** Caprais was previously the Chief Financial Officer of global industrial manufacturer ITT. ** This leadership change comes about seven months after Frederick Lowery succeeded Stanley Bergman as CEO; Bergman had led the company for 35 years. ** Among 18 brokers, 9 rate the stock as “buy” or above, 8 as “hold”, and 1 as “sell”; the median target price is $96—data compiled by LSEG. ** As of the previous trading day's close, the stock has risen 10.69% year-to-date.

路透社•2026/10/08 11:47

Movado to Sell 95% Stake in EBEL Luxury Watch Brand for $66.5 Million

07:34 AM EDT, 10/08/2026 (MT Newswires) -- Movado (MOV) said Thursday that it has agreed to sell a 95% stake in its EBEL luxury watch brand for $66.5 million to a group led by Montres Journe, with participation from Chanel and Pierre Jacques. The deal enables Movado to deepen its focus on its core luxury and fashion watch and jewelry products, it said. Movado said it will initially transfer EBEL's intellectual property, inventory, and certain other assets to a newly formed Swiss unit, while retaining a 5% stake in the business. The transaction, expected to close in the next few months, is subject to adjustments and closing conditions, the company said.

MT newswire•2026/10/08 11:34

Hydreight makes C$ 300,000 strategic investment in Insu Therapeutics

Hydreight Technologies disclosed a C$ 300,000 minority investment in Insu Therapeutics, completed on March 13, 2026. The deal also granted Hydreight U.S. distribution rights for peptide medicines using Insu’s buccal delivery technology, subject to development success. Insu received a USPTO Notice of Allowance on a buccal peptide-delivery patent application, reinforcing Hydreight’s strategic stake. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hydreight Technologies Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202610080730CANADANWCANADAPR_C0229) on October 08, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/08 11:31

BUZZ-KeyBanc upgrades Generac rating, boosted by Amazon deal, shares rise

On October 8th, after KeyBanc upgraded the rating of power equipment manufacturer Generac (GNRC.N) from "sector weight" to "overweight," Generac's stock price rose 1.2% in pre-market trading to $224. The brokerage stated that GNRC's data center power supply agreement with Amazon.com (AMZN.O) validates its position as a leading generator supplier. According to the brokerage, GNRC's management plans to achieve $3 billion to $3.2 billion in data center revenue by 2028 and remains confident in boosting supply chain capacity. KeyBanc also highlighted that, following multiple divestitures of portfolio assets, management continues to maintain a disciplined approach to capital allocation. As of the previous trading day's close, GNRC’s cumulative year-to-date gains exceeded 62%.

路透社•2026/10/08 11:16